Fig. 2From: Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case reportThe preoperative imaging of the patient’s intrahepatic lesion from October 9, 2020, to April 16, 2021Back to article page